FASN and lung cancer: We confirmed the results of iTRAQ by western blotting with protein samples from sensitive and resistant brain and lung cancer cells and demonstrated that NCI677397 markedly increased the expression of FDFT1, HMGCS1, FDPS, and FASN (Fig. 5C).